Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREPROSTINIL DIOLAMINE: 250 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
250
Total FAERS Reports
40 (16.0%)
Deaths Reported
136
Hospitalizations
250
As Primary/Secondary Suspect
11
Life-Threatening
3
Disabilities
Dec 20, 2013
FDA Approved
Prescription
Status

FDA Application: 203496 ·

Patent Expires: Jul 30, 2026 · First Report: 20061206 · Latest Report: 20250101

What Are the Most Common TREPROSTINIL DIOLAMINE Side Effects?

#1 Most Reported
Headache
86 reports (34.4%)
#2 Most Reported
Diarrhoea
68 reports (27.2%)
#3 Most Reported
Dyspnoea
59 reports (23.6%)

All TREPROSTINIL DIOLAMINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Headache 86 34.4% 8 44
Diarrhoea 68 27.2% 9 25
Dyspnoea 59 23.6% 12 37
Nausea 58 23.2% 6 26
Dizziness 34 13.6% 4 20
Flushing 28 11.2% 3 11
Vomiting 28 11.2% 2 12
Hypotension 26 10.4% 3 18
Dyspnoea exertional 25 10.0% 2 13
Malaise 25 10.0% 3 16
Pain in extremity 25 10.0% 2 7
Fatigue 24 9.6% 5 9
Pain in jaw 22 8.8% 2 10
Decreased appetite 19 7.6% 4 12
Pulmonary arterial hypertension 18 7.2% 7 15
Abdominal discomfort 17 6.8% 2 6
Chest pain 17 6.8% 1 12
Condition aggravated 17 6.8% 4 15
Death 16 6.4% 16 7
Pain 16 6.4% 0 7

Who Reports TREPROSTINIL DIOLAMINE Side Effects? Age & Gender Data

Gender: 79.2% female, 20.8% male. Average age: 55.7 years. Most reports from: US. View detailed demographics →

Is TREPROSTINIL DIOLAMINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2006 2 0 2
2007 2 2 2
2008 9 3 7
2009 6 4 4
2010 7 2 5
2011 11 3 7
2012 3 0 3
2013 4 1 3
2014 12 4 6
2015 34 3 20
2016 33 3 20
2017 6 2 4
2018 32 5 13
2019 7 2 4
2020 6 0 0
2021 5 2 4
2022 4 0 3
2023 1 0 1
2024 4 1 2
2025 1 0 1

View full timeline →

What Is TREPROSTINIL DIOLAMINE Used For?

IndicationReports
Pulmonary arterial hypertension 159
Product used for unknown indication 68
Pulmonary hypertension 17

TREPROSTINIL DIOLAMINE vs Alternatives: Which Is Safer?

TREPROSTINIL DIOLAMINE vs TRETINOIN TREPROSTINIL DIOLAMINE vs TRIAMCINOLONE TREPROSTINIL DIOLAMINE vs TRIAMCINOLONE ACETONIDE TREPROSTINIL DIOLAMINE vs TRIAMCINOLONE HEXACETONIDE TREPROSTINIL DIOLAMINE vs TRIAMTERENE TREPROSTINIL DIOLAMINE vs TRIATEC TREPROSTINIL DIOLAMINE vs TRIAZOLAM TREPROSTINIL DIOLAMINE vs TRICHLORMETHIAZIDE TREPROSTINIL DIOLAMINE vs TRICLOSAN TREPROSTINIL DIOLAMINE vs TRIENTINE

Official FDA Label for TREPROSTINIL DIOLAMINE

Official prescribing information from the FDA-approved drug label.